PH12022552013A1 - Novel medicament for treating hepatic encephalopathy - Google Patents

Novel medicament for treating hepatic encephalopathy

Info

Publication number
PH12022552013A1
PH12022552013A1 PH1/2022/552013A PH12022552013A PH12022552013A1 PH 12022552013 A1 PH12022552013 A1 PH 12022552013A1 PH 12022552013 A PH12022552013 A PH 12022552013A PH 12022552013 A1 PH12022552013 A1 PH 12022552013A1
Authority
PH
Philippines
Prior art keywords
hepatic encephalopathy
treating hepatic
novel medicament
medicament
treating
Prior art date
Application number
PH1/2022/552013A
Inventor
Kazuyuki Fujii
Daisuke Oka
Isao Shibuya
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of PH12022552013A1 publication Critical patent/PH12022552013A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a medicament for treating and/or preventing hepatic encephalopathy, comprising a quinolone compound as an active ingredient.
PH1/2022/552013A 2020-02-10 2021-02-09 Novel medicament for treating hepatic encephalopathy PH12022552013A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020020397A JP2023012557A (en) 2020-02-10 2020-02-10 Novel medicament for treating hepatic encephalopathy
PCT/JP2021/004730 WO2021161981A1 (en) 2020-02-10 2021-02-09 Novel medicament for treating hepatic encephalopathy

Publications (1)

Publication Number Publication Date
PH12022552013A1 true PH12022552013A1 (en) 2024-02-05

Family

ID=74844963

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2022/552013A PH12022552013A1 (en) 2020-02-10 2021-02-09 Novel medicament for treating hepatic encephalopathy

Country Status (7)

Country Link
JP (1) JP2023012557A (en)
KR (1) KR20220140560A (en)
CN (1) CN114929224A (en)
AU (1) AU2021220445B2 (en)
PH (1) PH12022552013A1 (en)
TW (1) TWI874582B (en)
WO (1) WO2021161981A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023308473A1 (en) * 2022-07-11 2025-02-20 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical compositions comprising a quinolone compound for irritable bowel syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI492943B (en) * 2008-12-05 2015-07-21 大塚製藥股份有限公司 Quinolone compound and pharmaceutical composition
SG2014004162A (en) * 2011-08-31 2014-03-28 Otsuka Pharma Co Ltd Quinolone compound
US20210317111A1 (en) * 2018-08-13 2021-10-14 Otsuka Pharmaceutical Co., Ltd. Novel medicament for treating inflammatory bowel disease

Also Published As

Publication number Publication date
JP2023012557A (en) 2023-01-26
TW202140006A (en) 2021-11-01
AU2021220445B2 (en) 2026-03-05
KR20220140560A (en) 2022-10-18
CN114929224A (en) 2022-08-19
WO2021161981A1 (en) 2021-08-19
AU2021220445A1 (en) 2022-09-29
TWI874582B (en) 2025-03-01

Similar Documents

Publication Publication Date Title
WO2020106647A3 (en) Combination therapy including a krasg12c inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
ZA202002139B (en) Combination pharmaceutical agents as rsv inhibitors
MX2022013612A (en) Combinations of lsd1 inhibitors for the treatment of hematological malignancies.
MY208545A (en) Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith
MY206796A (en) Substituted 4-aminoisoindoline-1,3-dione compounds and their use for treating lymphoma
MX2020001403A (en) Quinoline derivatives for treating infections with helminths.
AU2015336400A8 (en) Novel Aminoalkyl benzothiazepine Derivatives And Uses Thereof
MX2011010923A (en) Fused pyrrolopyridine derivative.
PH12020551751A1 (en) 2-amino-2-(1,2,3-triazole-4-yl)propane-1,3-diol derivative of novel compound for directly inhibiting asm activity, and use thereof
PH12020550491A1 (en) Pharmaceutical composition for preventing or treating acute myeloid leukemia or metastatic breast cancer
MY192088A (en) Combinantion therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
PH12021550304A1 (en) Novel medicament for treating inflammatory bowel disease
MY199762A (en) Moisturizing topical preparation
NZ745210A (en) Novel 2,3,5-substituted thiophene compound as protein kinase inhibitor
SG11201908234WA (en) Pharmaceutical composition comprising compound capable of penetrating blood-brain barrier as effective ingredient for preventing or treating brain cancer
PH12020500510A1 (en) Prophylactic and/or therapeutic agent for diseases involving ido expression
MX2019008338A (en) Pharmaceutical composition containing sulglycotide or pharmaceutically acceptable salt thereof for preventing or treating dry eye.
PH12022552013A1 (en) Novel medicament for treating hepatic encephalopathy
EP4428119A3 (en) Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof
GEP20247590B (en) Antibacterial quinolines
PH12022552015A1 (en) Novel medicament for treating inflammatory disease
PH12022551578A1 (en) Prophylactic and/or therapeutic agent for chronic prostatitis/chronic pelvic pain syndrome
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
MX2022003814A (en) 4-quinolinone antibacterial compounds.
MX2022003816A (en) Antibacterial compounds.